Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome

ObjectiveTo determine whether anti-Ro52 antibodies are associated with ILD in pSS.MethodsRetrospective study based on the presence or absence of anti-Ro52 antibodies in patients with pSS. Patients underwent chest HRCT at the time of diagnosis or during follow-up.ResultsSixty-eight patients were included. Two groups were defined by the presence (n = 31) or absence (n = 37) of anti-Ro52 antibodies. ILD was significantly higher in the presence of...